PT  - JOURNAL ARTICLE
AU  - Yeshwanter Radhakrishnan
AU  - Mohamed Hassanein
AU  - Brian Stephany
TI  - Management of COVID-19 in special populations with kidney disease
AID  - 10.3949/ccjm.87a.ccc067
DP  - 2020 Dec 03
TA  - Cleveland Clinic Journal of Medicine
4099  - http://www.ccjm.org/content/early/2020/12/01/ccjm.87a.ccc067.short
4100  - http://www.ccjm.org/content/early/2020/12/01/ccjm.87a.ccc067.full
AB  - Although the literature is limited, early evidence suggests that patients with chronic kidney disease, end-stage kidney disease, and kidney transplant recipients are at increased risk for severe COVID-19 disease and death. Hence, management should focus on both infection prevention and treatment. There is currently a lack of evidence and guideline recommendations on optimal management of immunosuppression in kidney transplant recipients with COVID-19 infection. This article focuses on the prevention and management of COVID-19 in patients with chronic kidney disease, patients with end-stage kidney disease on home hemodialysis and peritoneal dialysis, and kidney transplant recipients.